Suppr超能文献

贝赫切特病中的活化蛋白 C 抵抗。

Activated protein C resistance in Behcet's disease.

机构信息

Department of Internal Medicine, University of Missouri-Kansas City, Kansas, USA.

出版信息

Thromb J. 2013 Sep 2;11(1):17. doi: 10.1186/1477-9560-11-17.

Abstract

Behcet's disease is a chronic multi-system disorder of unknown etiology with protean manifestations. Venous thromboembolism is more common than arterial thrombosis, with deep vein thrombosis being the most frequent. Endothelial dysfunction resulting from vascular inflammation is considered to be an important factor of thrombosis, although the endothelial injury itself cannot completely explain the hypercoagulable state of the disease because other vasculitis syndromes do not increase the risk of thrombosis. The aim of this study is to evaluate the prevalence of activated protein C resistance (APC-R) in Egyptian patients with Behcet's disease. Also, to detect hyperhomocysteinemia in selected cases (with vascular complications) to assess their relationship with thromboembolic complications. The APC resistance ratio mean in the group of patients with vascular involvement was 2.6 ± 0.8 which was less than the group with no vascular involvement 2.8 ± 0.6, with non- significant P-value (0.5). There was more incidence of ocular lesions in the group of patients with high homocysteine level than the group of patients with normal homocytsteine level with significant P-value (0.08).

摘要

贝赫切特病是一种病因不明的慢性多系统疾病,表现多样。静脉血栓栓塞比动脉血栓形成更为常见,其中深静脉血栓形成最为常见。血管炎症导致的内皮功能障碍被认为是血栓形成的一个重要因素,尽管内皮损伤本身并不能完全解释疾病的高凝状态,因为其他血管炎综合征不会增加血栓形成的风险。本研究旨在评估埃及贝赫切特病患者中激活蛋白 C 抵抗(APC-R)的发生率。此外,在选定的病例(有血管并发症)中检测高同型半胱氨酸血症,以评估其与血栓栓塞并发症的关系。有血管受累的患者组 APC 抵抗比无血管受累的患者组 2.8±0.6 要低,差异无统计学意义(0.5)。高同型半胱氨酸血症组的眼部病变发生率高于同型半胱氨酸正常组,差异有统计学意义(0.08)。

相似文献

1
Activated protein C resistance in Behcet's disease.
Thromb J. 2013 Sep 2;11(1):17. doi: 10.1186/1477-9560-11-17.
2
Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Am J Ophthalmol. 2004 May;137(5):850-7. doi: 10.1016/j.ajo.2003.12.010.
3
Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1603-8. doi: 10.1007/s00417-008-0873-9. Epub 2008 Jul 5.
4
Behçet's disease and risk of vascular events.
Curr Opin Cardiol. 2016 Jul;31(4):451-7. doi: 10.1097/HCO.0000000000000281.
5
Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Br J Haematol. 2004 Aug;126(4):550-6. doi: 10.1111/j.1365-2141.2004.05072.x.
7
Vascular involvement in Behçet's disease: 8-year audit.
World J Surg. 1994 Nov-Dec;18(6):948-53; discussion 953-4. doi: 10.1007/BF00299119.
8
[Frequency and predictive factors of venous thrombosis in Behçet's disease].
Rev Med Interne. 2020 Sep;41(9):578-582. doi: 10.1016/j.revmed.2020.03.010. Epub 2020 May 27.
9
Haplotypes of the endothelial protein C receptor gene and Behçet's disease.
Thromb Res. 2012 Apr;129(4):459-64. doi: 10.1016/j.thromres.2011.07.032. Epub 2011 Aug 17.

本文引用的文献

1
A study on thrombophilic factors in Italian Behcet's patients.
Joint Bone Spine. 2010 Jul;77(4):330-4. doi: 10.1016/j.jbspin.2010.02.022. Epub 2010 May 8.
2
EULAR recommendations for the management of Behçet disease.
Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31.
3
Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
Clin Chem Lab Med. 2007;45(1):73-7. doi: 10.1515/CCLM.2007.018.
4
Homocysteine: an activity marker in Behçet's disease?
J Dermatol Sci. 2007 Feb;45(2):121-6. doi: 10.1016/j.jdermsci.2006.11.008. Epub 2006 Dec 19.
5
Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Br J Haematol. 2004 Aug;126(4):550-6. doi: 10.1111/j.1365-2141.2004.05072.x.
7
Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.
Blood Coagul Fibrinolysis. 2003 Feb;14(2):121-4. doi: 10.1097/00001721-200302000-00001.
8
Plasma homocysteine level and uveitis in Behçet's disease.
Isr Med Assoc J. 2002 Nov;4(11 Suppl):931-4.
9
Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
Thromb Res. 2002 Apr 1;106(1):19-24. doi: 10.1016/s0049-3848(02)00085-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验